Zentek and Medwell Forge Alliance to Revolutionize Healthcare with ZenGUARD™ Enhanced Surgical Masks

Zentek Ltd. and Medwell Solutions LLC have signed a definitive distribution agreement for the U.S. distribution of ZenGUARD Enhanced Surgical Masks. The agreement is effective from March 18, 2024, and spans two years following FDA market clearance. Medwell Solutions, a Dallas-based manufacturer and distributor, specializes in healthcare products and is recognized for its quality and experience in the field. Zentek's ZenGUARD technology enhances the viral filtration efficiency of masks and the partnership aligns with Zentek's goal of expanding its market reach.

Zentek and Medwell Forge a Strategic Alliance to Revolutionize the U.S. Healthcare Industry with ZenGUARD™ Enhanced Surgical Masks

GUELPH, ONTARIO, CANADA – March 18, 2024 – Zentek Ltd. (TSX: ZTEK), a trailblazing intellectual property development and commercialization enterprise, proudly announces a groundbreaking distribution agreement with Medwell Solutions LLC, a renowned Dallas-based healthcare product distributor. This partnership will propel the distribution of Zentek's revolutionary ZenGUARD™ Enhanced Surgical Masks throughout the vast healthcare landscape of the United States. Effective March 18, 2024, this two-year agreement will commence upon FDA market clearance.

A Synergy of Expertise: Empowering Healthcare Professionals

Medwell Solutions, a pillar of the healthcare industry, has established an unparalleled reputation for delivering exceptional products and services to healthcare facilities. Their comprehensive portfolio encompasses surgical devices, patient care supplies, and other essential consumables. With a proven track record spanning over two decades, Medwell's leadership has garnered extensive expertise in surgical technology and hospital supply chain management.

Zentek, the visionary behind ZenGUARD™ technology, has engineered a breakthrough solution to enhance the efficacy of face masks and HVAC systems in filtering viruses. Their state-of-the-art production facility in Guelph, Ontario, has earned ISO 13485:2016 certification, a testament to their unwavering commitment to medical device quality management systems.

Market Expansion and Supplier Diversity

This strategic partnership aligns seamlessly with Zentek's overarching goal of expanding its market reach. By leveraging Medwell's extensive distribution network and diverse supplier certifications, Zentek aims to make ZenGUARD™ masks readily accessible to healthcare professionals across the nation.

Executive Perspectives: A Shared Vision

Greg Fenton, CEO of Zentek, expressed unwavering confidence in the potential of this partnership: "Medwell's established sales channels and deep understanding of the healthcare market make them an ideal partner for the distribution of ZenGUARD™ masks. We are confident that their expertise will enable us to reach a broader audience and make a significant impact on the lives of healthcare professionals."

Keith J. Palmer, CEO of Medwell, echoed this enthusiasm: "We are thrilled to partner with Zentek and introduce ZenGUARD™ masks to the U.S. healthcare market. Their innovative technology aligns perfectly with our mission of providing cutting-edge solutions to healthcare providers. We believe that ZenGUARD™ masks have the potential to transform the industry, enhancing protection and improving patient outcomes."

Financial Insights: Assessing Zentek's Market Position

As Zentek embarks on this pivotal distribution agreement, investors and industry observers are closely scrutinizing the company's financial health and market performance.

• Market Capitalization (Adjusted): As of today, Zentek's market capitalization stands at $120.39 million USD.
• P/E Ratio (Adjusted): The company's price-to-earnings ratio, based on the last twelve months leading up to Q3 2024, is currently -13.79, indicating that it is not currently generating profits.
• Revenue Growth: Over the same period, Zentek has experienced a significant decline in revenue, with a -85.06% change as of Q3 2024.

InvestingPro Tips: Unlocking Zentek's Potential

Analysts at InvestingPro, a leading financial insights platform, offer valuable insights into Zentek's market positioning and competitive edge:

• Industry Niche Positioning: Zentek operates as a niche player in its industry, which could impact its ability to gain a substantial market share.
• Financial Stability: The company's liquid assets exceed its short-term obligations, providing a degree of financial stability in managing immediate responsibilities.
• Gross Profit Margins: Zentek's weak gross profit margins, reflected in a negative -841.52% over the last twelve months as of Q3 2024, could be a cause for concern.

Investors seeking a comprehensive analysis of Zentek's financial performance can explore InvestingPro's exclusive Tips at https://www.investing.com/pro/ZTEK. These insights encompass Zentek's debt levels, valuation multiples, and historical performance.

Exclusive Offer for Enhanced Insights

For investors seeking a deeper dive into Zentek's financial future, InvestingPro is offering an exclusive 10% off a yearly or biyearly Pro and Pro+ subscription with the coupon code PRONEWS24. This limited-time offer provides access to an enhanced toolset for making informed investment decisions.

Conclusion: A Transformative Partnership

The distribution agreement between Zentek and Medwell Solutions represents a pivotal moment for the healthcare industry. ZenGUARD™ Enhanced Surgical Masks, empowered by Zentek's innovative technology, are poised to revolutionize infection prevention practices, benefiting healthcare professionals and patients alike. This partnership will undoubtedly reshape the healthcare landscape, highlighting the power of collaboration in driving innovation and enhancing patient outcomes.